Search Our Research

Developing a National Breast Cancer Database for Research and Service Delivery

This year breast cancer became the most commonly diagnosed cancer in Australia. Although it has one ...
Read more...

Improving decision-making for post-operative, postmenopausal women with oestrogen-receptor positive early breast cancer.

The vast majority of women with breast cancer have oestrogen-receptor positive tumours. After their ...
Read more...

Uncovering new treatments for metastatic triple negative breast cancer

Triple negative breast cancers are an aggressive subtype that lacks expression of the Estrogen and H ...
Read more...

Blocking a gene driving triple negative breast cancer

A primary driving force behind the start and ongoing development of breast cancer is the activation ...
Read more...

Enhancing immunotherapy for breast cancer

An exciting cancer treatment, called immunotherapy, involves using the body’s own immune system to ...
Read more...

Developing a novel blood-based test for triple-negative breast cancer to inform treatment and care

Biomarkers are “biological markers” that can be measured from clinical samples, such as blood, a ...
Read more...

Expanding treatments for aggressive triple negative breast cancer

Triple negative breast cancer is an aggressive subtype of breast cancer. It has a 60% 5-year surviva ...
Read more...

Improving support for those returning to work following breast cancer

Going back to work after having time off for health-related reasons is beneficial for the individual ...
Read more...

Enhancing the immune response to breast cancer

While the overall prognosis for breast cancer has improved dramatically in recent years, there is st ...
Read more...

Improving understanding of early breast cancer within the milk ducts

Ductal carcinoma in situ (DCIS) is a breast tumour contained within the breast milk ducts without ha ...
Read more...